Clinical Study Shows Xpert® Xpress MVP Delivers Appropriate Treatment More Often to Women with Vaginal Symptoms

SUNNYVALE, Calif., July 7, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics, today announced the publication of a study demonstrating the real-world impact of the Xpert Xpress MVP (multiplex vaginal panel) test when used at the point of care. The study...